These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 21887406

  • 1. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J, Ligęza J, Klein A.
    Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
    [Abstract] [Full Text] [Related]

  • 2. The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145).
    Kisielewska J, Ligeza J, Klein A.
    Folia Histochem Cytobiol; 2008; 46(2):185-91. PubMed ID: 18519236
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 4. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 5. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM.
    Oncogene; 2002 Apr 25; 21(18):2785-96. PubMed ID: 11973637
    [Abstract] [Full Text] [Related]

  • 6. Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.
    Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M.
    Microvasc Res; 2008 May 25; 76(1):15-22. PubMed ID: 18440031
    [Abstract] [Full Text] [Related]

  • 7. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May 25; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 8. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 9. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S, Sugita H, Takamori H, Horino K, Nakahara O, Okabe H, Miyake K, Tanaka H, Beppu T, Baba H.
    Int J Oncol; 2012 Mar 27; 40(3):807-15. PubMed ID: 22025280
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.
    Jones HE, Goddard L, Gee JM, Hiscox S, Rubini M, Barrow D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI.
    Endocr Relat Cancer; 2004 Dec 27; 11(4):793-814. PubMed ID: 15613453
    [Abstract] [Full Text] [Related]

  • 11. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
    Azar ZM, Mehdi MZ, Srivastava AK.
    Can J Physiol Pharmacol; 2006 Jul 27; 84(7):777-86. PubMed ID: 16998541
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI.
    Endocrinology; 2005 Nov 27; 146(11):4609-18. PubMed ID: 16037379
    [Abstract] [Full Text] [Related]

  • 13. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J, Zhou Q, Shi XL, Jiang BH.
    Carcinogenesis; 2007 Mar 27; 28(3):713-23. PubMed ID: 17065200
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
    Wang X, Klein RD.
    Mol Carcinog; 2007 Nov 27; 46(11):912-23. PubMed ID: 17427962
    [Abstract] [Full Text] [Related]

  • 15. K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs.
    Minjgee M, Toulany M, Kehlbach R, Giehl K, Rodemann HP.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1506-14. PubMed ID: 21985943
    [Abstract] [Full Text] [Related]

  • 16. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X, Grasso AW, Kung HJ, Agarwal R.
    Cancer Res; 1998 May 01; 58(9):1920-9. PubMed ID: 9581834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D.
    Oncogene; 2005 Dec 01; 24(54):8025-37. PubMed ID: 16116481
    [Abstract] [Full Text] [Related]

  • 19. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

  • 20. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A, Vardatsikos G, Srivastava AK.
    Can J Physiol Pharmacol; 2009 Dec 10; 87(12):1009-18. PubMed ID: 20029537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.